Cargando…

Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion

Inflammatory breast cancer (IBC) is an aggressive form of primary breast cancer characterized by rapid onset and high risk of metastasis and poor clinical outcomes. The biological basis for the aggressiveness of IBC is still not well understood and no IBC‐specific targeted therapies exist. In this s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villodre, Emilly S., Hu, Xiaoding, Larson, Richard, Finetti, Pascal, Gomez, Kristen, Balema, Wintana, Stecklein, Shane R., Santiago‐Sanchez, Ginette, Krishnamurthy, Savitri, Song, Juhee, Su, Xiaoping, Ueno, Naoto T., Tripathy, Debu, Van Laere, Steven, Bertucci, François, Vivas‐Mejía, Pablo, Woodward, Wendy A., Debeb, Bisrat G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486564/ https://www.ncbi.nlm.nih.gov/pubmed/34342930 http://dx.doi.org/10.1002/1878-0261.13074

Ejemplares similares

Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer
por: Hu, Xiaoding, et al.
Publicado: (2021)

NDRG1 Expression Is an Independent Prognostic Factor in Inflammatory Breast Cancer
por: Villodre, Emilly S., et al.
Publicado: (2020)

Targeting Lipocalin-2 in Inflammatory Breast Cancer Cells with Small Interference RNA and Small Molecule Inhibitors
por: Santiago-Sánchez, Ginette S., et al.
Publicado: (2021)

High-fat diet, but not duration of lactation, increases mammary gland lymphatic vessel function and subsequent growth of inflammatory breast cancer cells
por: Balema, Wintana, et al.
Publicado: (2023)

Inflammatory breast cancer appearance at presentation is associated with overall survival
por: Balema, Wintana, et al.
Publicado: (2021)

Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism
por: Debeb, Bisrat G., et al.
Publicado: (2016)

Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model
por: Lacerda, Lara, et al.
Publicado: (2015)

Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free Survival
por: Stecklein, Shane R., et al.
Publicado: (2017)

Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer
por: Santiago-Sánchez, Ginette S., et al.
Publicado: (2020)

The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancer
por: Ning, Jing, et al.
Publicado: (2019)

Differential Effect of Phosphorylation-Defective Survivin on Radiation Response in Estrogen Receptor-Positive and -Negative Breast Cancer
por: Debeb, Bisrat G., et al.
Publicado: (2015)

Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10(th) Anniversary Conference
por: Woodward, Wendy A., et al.
Publicado: (2017)

NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non‐inflammatory breast cancers
por: Bertucci, François, et al.
Publicado: (2020)

The Antihelmintic Drug Pyrvinium Pamoate Targets Aggressive Breast Cancer
por: Xu, Wei, et al.
Publicado: (2013)

Tetrandrine, a Compound Common in Chinese Traditional Medicine, Preferentially Kills Breast Cancer Tumor Initiating Cells (TICs) In Vitro
por: Xu, Wei, et al.
Publicado: (2011)

EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer
por: Wang, Xiaoping, et al.
Publicado: (2022)

Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer
por: Gagliardi, Maria, et al.
Publicado: (2020)

Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers
por: Masuda, Hiroko, et al.
Publicado: (2013)

Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer
por: Bambhroliya, Arvind, et al.
Publicado: (2018)

Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models
por: Wolfe, Adam R., et al.
Publicado: (2016)

Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer
por: Kida, Kumiko, et al.
Publicado: (2020)

BSCI-07. Multiomics characterization of brain metastases in multiple histologies identifies enrichment of oxidative phosphorylation as a promising therapeutic target
por: Fukumura, Kazutaka, et al.
Publicado: (2021)

Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC
por: Iwase, Toshiaki, et al.
Publicado: (2020)

Prophylactic cranial irradiation reduces the incidence of brain metastasis in a mouse model of metastatic, HER2-positive breast cancer
por: Smith, Daniel L., et al.
Publicado: (2021)

Influence of Macrophages on Vascular Invasion of Inflammatory Breast Cancer Emboli Measured Using an In Vitro Microfluidic Multi-Cellular Platform
por: Gadde, Manasa, et al.
Publicado: (2023)

Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells
por: Debeb, Bisrat G, et al.
Publicado: (2010)

Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells
por: Cohen, Evan N., et al.
Publicado: (2015)

Autophagy Interplay with Apoptosis and Cell Cycle Regulation in the Growth Inhibiting Effect of Resveratrol in Glioma Cells
por: Filippi-Chiela, Eduardo C., et al.
Publicado: (2011)

EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer
por: Debeb, Bisrat G, et al.
Publicado: (2014)

Isolation of Oct4-Expressing Extraembryonic Endoderm Precursor Cell Lines
por: Debeb, Bisrat G., et al.
Publicado: (2009)

Inflammatory breast cancer: a model for investigating cluster-based dissemination
por: Jolly, Mohit Kumar, et al.
Publicado: (2017)

Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells
por: Klopp, Ann H., et al.
Publicado: (2010)

Predicting Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy Using a Deep Convolutional Neural Network–Based Artificial Intelligence Tool
por: Krishnamurthy, Savitri, et al.
Publicado: (2023)

SPDL1 Is an Independent Predictor of Patient Outcome in Colorectal Cancer
por: Klimaszewska-Wiśniewska, Anna, et al.
Publicado: (2022)

Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC
por: Rypens, Charlotte, et al.
Publicado: (2022)

Tear Lipocalin and Lipocalin-Interacting Membrane Receptor
por: Glasgow, Ben J.
Publicado: (2021)

Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype
por: Harano, Kenichi, et al.
Publicado: (2018)

Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors
por: Bertucci, François, et al.
Publicado: (2021)

PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy
por: Bertucci, François, et al.
Publicado: (2015)

LipocalinPred: a SVM-based method for prediction of lipocalins
por: Ramana, Jayashree, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_gfuoijjdiimtvt2uafojl9usfe